MOTS-c for Biological Age Reduction — Peptide Longevity Fewer than 15% of people who try peptide therapies for longevity understand the distinction between slowing aging and reversing it. MOTS-c for biological age reduc…
Read articleMOTS-c Support Biological Age Reduction? (Evidence Review) A 2020 study published in Cell Metabolism found that MOTS-c administration improved insulin sensitivity by 32% in middle-aged mice and extended lifespan markers…
Read articlePeptides for NAD Decline Research Compared — Real Peptides Most NAD+ restoration protocols focus on supplementation. Nicotinamide riboside, NMN, niacin. But emerging research shows peptide-based interventions restore NA…
Read articleBest Research Peptides for NAD Decline Research — 2026 NAD+ (nicotinamide adenine dinucleotide) levels drop by approximately 50% between ages 40 and 60. Not from lack of precursor intake but from impaired cellular synth…
Read articleMK-677 Frailty Research Mechanism — Growth Hormone Pathway A 2023 study published in The Journals of Gerontology found that frailty affects approximately 15% of adults over 65, with muscle loss and declining bone densit…
Read articleMK-677 for Frailty Research — Ghrelin Agonist Insights MK-677 isn't a steroid. It's a growth hormone secretagogue that mimics ghrelin, the 'hunger hormone' that also signals the pituitary to release GH and IGF-1. For fr…
Read articleDoes MK-677 Help Frailty Research? (Current Evidence) A 2018 study published in The Journal of Clinical Endocrinology & Metabolism found that elderly participants taking MK-677 (ibutamoren) for 12 months showed a 1.1 kg…
Read articleDoes Sermorelin Help Frailty Research? (Clinical Evidence) A 2023 cohort study published in The Journals of Gerontology found that adults over 65 treated with sermorelin acetate for 16 weeks demonstrated 14.7% greater l…
Read articleMK-677 Studied Frailty Research — Clinical Evidence Review Research conducted at the University of Virginia published in The Journal of Clinical Endocrinology & Metabolism found that MK-677 (ibutamoren) increased lean b…
Read articleDoes MK-677 Help Sarcopenia Research? (Current Evidence) A 2019 pre-clinical study from the University of Kentucky found that MK-677 (ibutamoren) preserved lean muscle mass and grip strength in aged mice with induced sa…
Read articleMK-677 for Sarcopenia Research — Mechanism & Evidence Most sarcopenia interventions target protein synthesis without addressing the upstream hormone collapse that makes muscle preservation impossible after age 60. Resea…
Read articleMK-677 Sarcopenia Research Mechanism — Clinical Evidence A 2022 Phase 2 trial published in the Journal of Clinical Endocrinology & Metabolism found that elderly participants receiving MK-677 (ibutamoren) gained an avera…
Read articleBPC-157 Chronic Pain Research Mechanism — How It Works The most surprising thing about BPC-157 chronic pain research isn't that it works. It's how it works. Unlike conventional analgesics that block pain receptors or su…
Read articleDoes BPC-157 Help Chronic Pain Research? Evidence Review Without placebo-controlled human trials, calling any peptide 'proven' for chronic pain is misleading at best. BPC-157 (Body Protection Compound-157) is a 15-amino…
Read articleBPC-157 Studied Chronic Pain Research — Clinical Findings Without targeted tissue repair mechanisms, most analgesics address chronic pain by blocking nociceptive signals. Leaving the underlying structural damage unresol…
Read articleBPC-157 for Chronic Pain Research — Current Evidence Fewer than 12% of compounds demonstrating analgesic effects in rodent models produce meaningful pain reduction in human trials. And BPC-157, a synthetic pentadecapept…
Read articleBPC-157 Fibromyalgia Research Mechanism — How It Works Fibromyalgia affects approximately 4% of adults worldwide, characterised by chronic widespread pain, fatigue, and cognitive dysfunction. Yet no FDA-approved medicat…
Read articleBPC-157 Studied Fibromyalgia Research — Real Science Fibromyalgia affects 2–6% of the population, yet no medication approved for it addresses the core pathology. Most treatments target downstream symptoms like pain ampl…
Read articleDoes BPC-157 Help Fibromyalgia? Research Insights A 2023 rodent study published by researchers at the University of Zagreb demonstrated that BPC-157 administration reduced inflammatory cytokine expression in CNS tissue …
Read articleBPC-157 Studied Diabetic Neuropathy Research — Real Peptides Fewer than 15% of compounds showing neuroprotective effects in diabetic rat models ever demonstrate meaningful clinical translation. BPC-157 studied diabetic …
Read article